Paper31453
Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans.
Greenblatt DJ and 7 others. J Pharm Sci, 1979. Cited by 185 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. Papers, record 31453. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31453
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Lorazepam | Major topic |
| Administration, Oral | |
| Adult | |
| Biological Availability | |
| Female | |
| Half-Life | |
| Humans | |
| Infusions, Parenteral | |
| Injections, Intramuscular | |
| Kinetics | |
| Male | |
| Models, Biological |
Source PubMed
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 185 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,422,080 | Lorazepam during breastfeeding: a pharmacokinetic case report and exploratory pharmacovigilance assessment - a contribution from the ConcePTION project. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42422080 | PubMed |
| 39,891,951 | Revisiting the lorazepam challenge: An algorithm for clinical-decision making. | Gen Hosp Psychiatry | 2025 | https://conductscience.org/library/papers/39891951 | PubMed |
| 36,571,702 | Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals. | Clin Pharmacokinet | 2023 | https://conductscience.org/library/papers/36571702 | PubMed |
| 34,002,290 | Towards Evidence-Based Weaning: a Mechanism-Based Pharmacometric Model to Characterize Iatrogenic Withdrawal Syndrome in Critically Ill Children. | AAPS J | 2021 | https://conductscience.org/library/papers/34002290 | PubMed |
| 33,920,722 | Time Is Brain: Acute Control of Repetitive Seizures and Status Epilepticus Using Alternative Routes of Administration of Benzodiazepines. | J Clin Med | 2021 | https://conductscience.org/library/papers/33920722 | PubMed |
| 33,424,499 | Exposure-Based Methadone and Lorazepam Weaning Protocol Reduces Wean Length in Children. | J Pediatr Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33424499 | PubMed |
| 33,163,069 | Consumption of psychotropic medicines at a referral hospital in Namibia: findings and implications. | Afr Health Sci | 2020 | https://conductscience.org/library/papers/33163069 | PubMed |
| 32,757,149 | Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials. | Drugs R D | 2020 | https://conductscience.org/library/papers/32757149 | PubMed |
| 30,964,947 | Potential prediction of formulation performance in paediatric patients using biopharmaceutical tools and simulation of clinically relevant administration scenarios of nifedipine and lorazepam. | Br J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/30964947 | PubMed |
| 28,101,764 | Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal. | CNS Drugs | 2017 | https://conductscience.org/library/papers/28101764 | PubMed |
| 27,943,220 | Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus. | Clin Pharmacokinet | 2017 | https://conductscience.org/library/papers/27943220 | PubMed |
| 27,585,904 | Clinical Pharmacology Studies in Critically Ill Children. | Pharm Res | 2017 | https://conductscience.org/library/papers/27585904 | PubMed |
| 26,603,741 | Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy. | CNS Drugs | 2015 | https://conductscience.org/library/papers/26603741 | PubMed |
| 23,344,790 | A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam. | AAPS J | 2013 | https://conductscience.org/library/papers/23344790 | PubMed |
| 22,133,324 | Pharmacological management of acute and persistent aggression in forensic psychiatry settings. | CNS Drugs | 2011 | https://conductscience.org/library/papers/22133324 | PubMed |
| 20,218,012 | Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/20218012 | PubMed |
| 15,916,448 | Pharmacological management of acute agitation. | Drugs | 2005 | https://conductscience.org/library/papers/15916448 | PubMed |
| 15,335,224 | New treatments for agitation. | Psychiatr Q | 2004 | https://conductscience.org/library/papers/15335224 | PubMed |
| 14,748,812 | Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14748812 | PubMed |
| 12,898,042 | [Psychopharmacological treatment in the pre-clinical emergency medicine]. | Anaesthesist | 2003 | https://conductscience.org/library/papers/12898042 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31453
GET https://conductscience.org/api/papers/v1/31453/cited_by?page=2